Google

Google is a multinational technology company renowned for its search engine, offering services such as Gmail, Google Drive, Google Docs, and YouTube. It specializes in advertising solutions through Google Ads and mobile operating systems with Android, while actively innovating in artificial intelligence and machine learning.

Ekta Aggarwal

Principal Account Manager

John Bell

CEO-Founder

Henry Boulton

CEO

Co khi Nhan Do

CEO

Sumiran Das

Growth Equity Investor at Google Capital

Jacquelline Fuller

President

Raj Gajwani

Director, Orion Wifi @ Google Area 120

Carletta Higginson

Director, Global Head of Music Publishing

Rahul Jain

Lead, Venture Capital and Startups - Google Cloud

Aftab Jutt

CEO

Sushrut Karanjkar

Director

Jess Kuizon

CEO

Anthony Nakache

Managing Director, Google MENA

Anna Patterson

Founder and Managing Partner at Gradient Ventures

Philipp Schindler

Senior Vice President and Chief Business Officer

Andrew R. Whalley

Director, Chrome Security

Krishna Yeshwant

Partner

LightRoom Premium Mod APK Download Android

CEO

Past deals in Growth Stage

Push Security

Series B in 2025
Push Security is a cybersecurity software company focused on protecting identities and preventing identity-based attacks. It provides a browser-based agent that observes how employees use and create identities, generating telemetry that can be viewed in the Push platform or forwarded to SIEM or SOAR systems. The software enables security teams to monitor and secure the entire identity attack surface and detect and block identity-based threats, including advanced phishing techniques. It enforces in-browser controls to block, warn, or guide employees to prevent breaches. The solution also offers clear, step-by-step guidance on implementing essential security controls and uses automation to accelerate deployment, helping organizations improve security without adding costly tools or complex deployments.

Omni

Series B in 2025
Omni is a technology company specializing in business intelligence platforms. It offers a unique solution that combines the consistency of a shared data model with the flexibility of SQL, enabling users to efficiently analyze and share reliable metrics while avoiding unnecessary complexity.

Blockaid

Series B in 2025
Blockaid is a technology company that specializes in digital security. It develops a security platform designed to safeguard users from fraud, phishing, and hacks. The company employs a range of security features, including blockchain technology, to ensure the safety and security of users' data. This enables online businesses to offer their services with confidence, knowing that their customers' data is protected.

Sardine

Series C in 2025
Sardine is a financial technology company that specializes in providing a risk and fraud infrastructure tailored for the online economy. It has developed a device intelligence platform that leverages artificial intelligence and advanced risk engine software. This platform enhances fraud detection while minimizing sign-up friction by analyzing multiple real-time data points, including device information, browser details, and behavioral biometrics. By integrating this technology, Sardine enables businesses to establish a robust risk and fraud management framework, ultimately reducing costs within the fintech ecosystem.

Allara Health

Series B in 2025
Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.

Leyden Labs

Series B in 2025
Leyden Labs develops a Mucosal Protection Platform to protect against respiratory viruses, including influenza and coronaviruses. The company offers a portfolio of broad protective nasal sprays designed to reduce the risk of infection and limit transmission, aiming to improve public health through innovative protection methods. Its team combines biotechnology veterans with new talent to advance solutions that address common viral threats at the mucosal surface.

Cala Health

Series C in 2024
Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.

Roboflow

Series B in 2024
Founded in 2019, Roboflow develops software tools that empower software engineers to build computer vision applications more efficiently. Its platforms, including Roboflow Organize and Roboflow Pro, streamline dataset management, offer insights, enable image transformations, facilitate integrations, and allow sharing, thereby accelerating the development process.

Vitara Biomedical

Series B in 2024
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Metsera

Series B in 2024
Metsera is a clinical-stage biopharmaceutical company specializing in developing innovative therapies for obesity and metabolic conditions. It focuses on advancing oral and injectable treatments, integrating proprietary health technology tools for personalized care.

PeopleOne Health

Series B in 2024
PeopleOne Health delivers advanced healthcare solutions that integrate treatment and prevention, resulting in substantial cost savings for employers (up to 30%) and improved employee recruitment/retention. Employees enjoy complimentary access to top-tier doctors and healthcare professionals, with a focus on comprehensive primary care and mental health support.

Infinitus Systems

Series C in 2024
Infinitus Systems automates phone calls in healthcare using AI. It streamlines administrative tasks like insurance eligibility checks, improving efficiency, reducing costs, and enhancing patient care.

Scope3

Series B in 2024
Scope3 provides a supply chain emissions data platform that serves as the source of truth for corporate greenhouse gas information. The company models the core inputs and outputs of products and services across the supply chain, designs systems to reduce environmental impact, and produces monthly sustainability reports that update with fresh data. This enables organizations to factor emissions into business decisions, respond rapidly to changes, and receive recognition for investments in reducing their carbon footprint.

Dandelion Energy

Series C in 2024
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Mechanical Orchard

Series B in 2024
Mechanical Orchard is a technology company based in San Francisco that specializes in modernizing and managing critical business applications for large enterprises. By de-risking the process of updating legacy computer systems, the company helps its clients remain competitive in a rapidly evolving marketplace. Mechanical Orchard focuses on developing custom applications for cloud operations, employing advanced product development, software engineering, and DevOps practices to address complex challenges. The firm aims to ensure that businesses can run secure, reliable, and scalable applications, enabling them to stay ahead of the curve in their respective industries.

Altana Technologies

Series C in 2024
Altana Technologies is a company that specializes in transforming both public and non-public data into an intelligent, interconnected map of the global supply chain. By utilizing its platform, Altana Atlas, the company enables enterprises, governments, and logistics providers to connect and collaborate, fostering trust and transparency across business networks. The platform offers comprehensive trade data management services by integrating internal and external data, providing clean data sets, and delivering real-time insights related to transactions, ownership, movements, and risks in the global trade network. Through advanced machine learning techniques, Altana Technologies equips organizations across various sectors with the tools to enhance the safety, efficiency, and profitability of trade, contributing to a more resilient, secure, and sustainable approach to globalization.

Harvey

Series C in 2024
Harvey offers AI-powered solutions designed to streamline legal work for law firms and corporate legal teams. Its tools assist with tasks like document review, contract analysis, legal research, and due diligence, helping professionals save time and improve accuracy. The platform uses natural language processing to interpret complex legal language and generate relevant insights. Harvey’s services are tailored to meet the specific needs of clients across various practice areas. .

Cardurion Pharmaceuticals

Series B in 2024
Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.

Hebbia

Series B in 2024
Founded in 2020, Hebbia develops AI productivity tools for knowledge workers. Its platform breaks down complex tasks into manageable steps, enabling professionals across finance, law, and other sectors to efficiently process large volumes of documents using generative models.

Santa Ana Bio

Series B in 2024
Santa Ana Bio is a biotechnology company specializing in the development of precision immunology therapies for autoimmune diseases. It employs advanced multi-omics platforms and antibody engineering techniques to design targeted biologics, aiming to improve patient outcomes and quality of life.

StrongDM

Series C in 2024
StrongDM, Inc. is a technology company based in Burlingame, California, founded in 2015. The company offers a platform designed to manage and audit access to various databases and servers for employees, vendors, and cloud-based tools. Its services enable organizations to efficiently create and remove users, manage permissions, and ensure proper data handling. StrongDM's platform simplifies the process of controlling access across multiple systems, enhancing security and compliance. In 2016, the company gained recognition as the Audience Favorite at the Strata+Hadoop World conference, highlighting its impact in the data management sector.

Cerevance

Series B in 2024
Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

Midi Health

Series B in 2024
Midi Health is a virtual care clinic specializing in women's health. It offers personalized treatment protocols for depression, gynecological cancer, and menstrual issues, delivered by clinicians trained in female midlife health. The platform leverages at-home labs, prescription medications, supplements, and lifestyle coaching to provide comprehensive care.

Ripcord

Venture Round in 2024
Ripcord is a robotic digitization company that develops platforms and software to convert physical documents into digital, searchable data and streamlined workflows. Its Canopy solution uses artificial intelligence and machine learning to capture, enrich, and organize content, enabling enterprises to simplify processes and improve accuracy. The company combines sensors, automation, and vision-guided robots to create a digital twin of information, perform document scanning and recognition, and accelerate data capture, organization, and retrieval. This supports faster, higher-quality processing and moves organizations toward paperless document management and more efficient operations. Headquartered in Los Angeles, Ripcord was founded in 2014.

Alethea

Series B in 2024
Alethea is a technology company helping the Fortune 500, private companies and nonprofits protect themselves from harms stemming from disinformation. Leveraging its multi-channel machine learning platform, Artemis, Alethea detects disinformation narratives across the internet, enabling customers to proactively defend against this pervasive threat. With Artemis-powered early detection, Alethea customers can protect their reputations, key assets, physical safety and market value. The company was founded in 2019 and is woman owned.

Oula Health

Series B in 2024
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Accent Therapeutics

Series C in 2024
Accent Therapeutics, Inc. is a biopharmaceutical company focused on developing small molecule therapies for oncology, utilizing the emerging field of epitranscriptomics. Founded in 2017 and headquartered in Lexington, Massachusetts, the company explores the post-transcriptional chemical modifications of RNA, which play a crucial role in regulating proteins essential for cellular growth and differentiation. By precisely targeting cancer-associated RNA-modifying proteins, Accent Therapeutics aims to innovate and deliver transformative therapies that can significantly improve patient outcomes in cancer treatment.

Comanche Biopharma

Series B in 2024
Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. Its mission is to provide safe, effective, evidence-based, and affordable therapies for treating life-threatening complications of pregnancy.

Lightmatter

Series C in 2023
Founded in 2017 and based in Boston, Lightmatter is an artificial intelligence hardware company that specializes in integrated optical technology. It designs photonic chips to enable data processing and communication through light signals, aiming to improve efficiency and scalability for AI data centers.

Seismic Therapeutic

Series B in 2023
Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.

Censys

Series C in 2023
Founded in 2017, Censys offers an internet intelligence platform that provides real-time visibility into global networks and devices. Its solution enables businesses to discover unknown assets, monitor remote workforce, identify threat actors, and manage attack surfaces proactively.

Signos

Series B in 2023
Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Scope3

Series B in 2023
Scope3 provides a supply chain emissions data platform that serves as the source of truth for corporate greenhouse gas information. The company models the core inputs and outputs of products and services across the supply chain, designs systems to reduce environmental impact, and produces monthly sustainability reports that update with fresh data. This enables organizations to factor emissions into business decisions, respond rapidly to changes, and receive recognition for investments in reducing their carbon footprint.

ROME Therapeutics

Series B in 2023
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

AI21 Labs

Series C in 2023
AI21 Labs is an Israeli artificial intelligence company that develops generative AI and large language models along with tools to understand and generate natural language. Founded in 2017 and based in Tel Aviv-Yafo, it provides AI-based writing and reading assistance that understands context and meaning, including a writing companion that can rephrase text to convey the intended message and generate summaries. The company's tools help users read more efficiently, analyze and visualize complex knowledge structures, and apply deep learning and NLP to transform writing and comprehension for businesses and individuals.

Modular

Series B in 2023
Modular is an artificial intelligence software development platform that aims to streamline the development and deployment of AI technologies. The company focuses on creating a user-friendly environment that enhances the speed and efficiency of developers by providing a unified interface for popular AI frameworks. Its platform is designed to support a variety of hardware backends and cloud environments, facilitating easy integration into existing workflows without the need for significant code rewrites or architectural changes. By combining high-quality infrastructure with a focus on usability and flexibility, Modular seeks to empower developers to work more effectively, ultimately accelerating the advancement of AI solutions across diverse applications.

deepset

Series B in 2023
Deepset is a technology company that specializes in natural language processing (NLP) solutions, providing tools and frameworks for enterprise AI teams. Established in 2018, the company is known for its Haystack open-source framework, which facilitates the development of NLP applications. Deepset's software leverages advancements in machine learning and transfer learning to enable users to extract value from diverse text sources and create customized models with reduced training data requirements. Through its offerings, deepset has supported numerous AI teams worldwide in applying cutting-edge NLP technologies to practical, real-world challenges. Additionally, the company provides deepset Cloud, an LLM platform that enhances collaboration and efficiency for enterprises focused on AI development.

Typeface

Series B in 2023
Typeface is a generative AI application for creating enterprise content. It enables organizations to accelerate the production of on-brand content by combining speed, brand personalization, and governance across the content lifecycle. The platform offers self-service content development tools that cover the entire lifecycle, enabling employees to craft content with ease, speed, and brand authenticity while maintaining consistency. Typeface provides proactive suggestions to improve content and helps enterprises uphold brand standards as content scales across teams.

Runway

Series C in 2023
Runway, established in 2018, specializes in applied AI research and development. It offers an innovative video editing platform for professionals, utilizing AI-powered tools that enable intuitive manipulation and creation of visual content through text-based commands.

Nothing

Series C in 2023
Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. It aims to remove barriers between people and technology by focusing on product integration and user experience. The company offers mobile devices and personalized noise-cancellation earbuds featuring wireless charging, water resistance, and dual connectivity. Through its innovative approach, Nothing seeks to create a seamless digital ecosystem that combines hardware and software, providing customers with reliable and durable technology at affordable prices.

Redpanda Data

Series C in 2023
Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

Warp

Series B in 2023
Warp is a developer of a Rust-based coding terminal aimed at enhancing productivity in coding and application development. Its software innovatively transforms the traditional command-line interface by dividing the terminal output into a sequence of commands, rather than presenting it as a single buffer. This approach replaces the standard character buffer with a comprehensive text editor, allowing software developers to efficiently navigate, copy, save, and share their work. Warp's terminal redefines the user experience by evolving from a single-user utility into a collaborative platform, where sessions, blocks, and environments are persistent, searchable, and easily shared via links.

Synthesia

Series C in 2023
Founded in London in 2017, Synthesia Ltd. specializes in AI-driven video generation platforms. Its technology transforms text into professional videos with customizable avatars and voiceovers in over 140 languages, enabling efficient creation of personalized advertising, corporate communications, e-learning content, and more.

Lightmatter

Series C in 2023
Founded in 2017 and based in Boston, Lightmatter is an artificial intelligence hardware company that specializes in integrated optical technology. It designs photonic chips to enable data processing and communication through light signals, aiming to improve efficiency and scalability for AI data centers.

Pixxel

Venture Round in 2023
Pixxel is space data company that develops hyperspectral earth-imaging satellite constellations to provide global coverage, capturing geospatial data for applications such as climate monitoring, crop yield prediction, urban planning, and disaster response. The constellation aims to deliver near-daily imagery, enabling detection, monitoring, and prediction of global phenomena. The company also offers satellites as a service, allowing clients to access and operate imaging assets to monitor changing environmental, economic, and security conditions. Founded in 2018 and headquartered in Bengaluru, India.

AMP

Series C in 2023
AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Clever Care Health Plan

Series C in 2023
Founded in 2019, Clever Care Health Plan specializes in Medicare Advantage plans that integrate Eastern and Western medicine. It offers culturally sensitive healthcare solutions, including acupuncture, herbal remedies, tai chi, qi gong, cupping, and moxibustion treatments. The company connects members to diverse networks of hospitals, doctors, brokers, and member advocates.

Chroma Medicine

Series B in 2023
Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Aera Therapeutics

Series B in 2023
Aera Therapeutics is a biotechnology company focused on advancing genetic medicines through its proprietary protein nanoparticle (PNP) delivery platform. This innovative platform utilizes endogenous human proteins derived from retroelements, which self-assemble into capsid-like structures capable of packaging and transferring nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to enhance the efficacy and reach of genetic therapies across various tissues and disease areas. Additionally, the company holds a licensed technology that features a therapeutic enzyme platform based on novel, compact, and programmable gene-editing enzymes, further expanding its capabilities in the field of genetic medicine.

Cerevance

Series B in 2023
Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

Mill Industries

Venture Round in 2023
Mill Industries develops and rents smart kitchen bins that chop, dry, shrink, and deodorize food waste overnight, turning it into a coffee‑ground‑like material. The system is digitally connected, allowing users to monitor usage and receive free shipping of the dried residue to a partner facility that converts it into animal feed or compost. By reducing household waste and enabling efficient recycling, the company addresses climate‑related food waste challenges.

Oxa Autonomy

Series C in 2023
Oxa Autonomy develops AI-based software for autonomous vehicle fleets. Their platform enables safe navigation in varied environments, enhancing positioning accuracy and predicting vehicle movements.

Chronosphere

Venture Round in 2023
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Carrick Therapeutics

Series C in 2022
Founded in 2015, Carrick Therapeutics is a biopharmaceutical company based in Dublin, Ireland. It specializes in developing innovative cancer therapeutics that target molecular pathways driving aggressive and resistant forms of cancer, aiming to transform cancer treatment.

Pangea

Series B in 2022
Pangea is a developer of security APIs that offers a comprehensive portfolio of security services tailored for application builders. The company provides a single platform that simplifies the integration of security into cloud and mobile applications. Pangea's services are designed to be globally accessible while maintaining regional intelligence, making them suitable for diverse markets. Available on major cloud platforms such as AWS and GCP, Pangea enables clients—including app developers, SaaS providers, and security operations teams—to efficiently create secure and compliant user experiences. The company aims to make security accessible to all developers, eliminating the need for extensive security expertise.

Dandelion Energy

Series B in 2022
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

AMP

Series C in 2022
AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Landis

Series B in 2022
Founded in 2018, Landis is a real estate technology company based in New York. It specializes in helping renters become homeowners by allowing customers to select their dream home, rent it initially, and purchase it anytime within the first twelve months. The company also assists customers in building credit and saving for a down payment, providing a transparent process for transitioning from renting to owning.

Progcap

Series C in 2022
Progcap is a fintech lender in India that provides working capital to micro and small businesses, focusing on underbanked semi-urban and rural retailers, underwriting credit with non-traditional ecosystem data and risk models to enable collateral-free financing and supply chain-based funding solutions; founded in 2017 and headquartered in New Delhi, the company leverages technology to deliver affordable and timely credit to its customers.

Altana Technologies

Series B in 2022
Altana Technologies is a company that specializes in transforming both public and non-public data into an intelligent, interconnected map of the global supply chain. By utilizing its platform, Altana Atlas, the company enables enterprises, governments, and logistics providers to connect and collaborate, fostering trust and transparency across business networks. The platform offers comprehensive trade data management services by integrating internal and external data, providing clean data sets, and delivering real-time insights related to transactions, ownership, movements, and risks in the global trade network. Through advanced machine learning techniques, Altana Technologies equips organizations across various sectors with the tools to enhance the safety, efficiency, and profitability of trade, contributing to a more resilient, secure, and sustainable approach to globalization.

Adda247

Series B in 2022
Adda247 is an edtech platform based in Gurugram, India, specializing in the preparation for government examinations. Founded in 2010, the company provides a comprehensive learning ecosystem that includes online courses, study materials, and test series for various competitive exams. As a subsidiary of Metis Eduventures Private Limited, Adda247 aims to empower students with the resources needed to succeed in their academic and career pursuits in the public sector. The platform leverages technology to deliver accessible and effective educational solutions, making it a prominent player in the Indian education landscape.

Flatfile

Series B in 2022
Flatfile is a data onboarding platform that enables developers to validate, map, and import customer data from spreadsheets into software applications. It embeds a JavaScript snippet to add an import button in web apps and provides a secure Concierge workspace for collaboration to manage data ingestion. The platform supports CSV, XLS, and TSV uploads, allows users to configure a target model for data validation, and learns over time to improve accuracy. It is API-first and widely adopted by hundreds of companies, including AstraZeneca, Square, and Sage.

SpinLaunch

Series B in 2022
SpinLaunch Inc. is a spaceflight technology development company based in Long Beach, California, founded in 2014. The company specializes in creating an innovative launch system that utilizes a large mass accelerator, or centrifuge, to propel payloads into space without the use of chemical propellants. This kinetic space launch system is designed to enable on-demand launches of small satellites under various weather conditions. By spinning the payload in a vacuum to minimize friction, SpinLaunch aims to achieve speeds of approximately 3,000 miles per hour, allowing objects to be launched directly into space or providing initial thrust for further ascent with supplemental rockets. Through this approach, SpinLaunch seeks to offer a more cost-effective and sustainable alternative to traditional space launch methods.

Sardine

Series B in 2022
Sardine is a financial technology company that specializes in providing a risk and fraud infrastructure tailored for the online economy. It has developed a device intelligence platform that leverages artificial intelligence and advanced risk engine software. This platform enhances fraud detection while minimizing sign-up friction by analyzing multiple real-time data points, including device information, browser details, and behavioral biometrics. By integrating this technology, Sardine enables businesses to establish a robust risk and fraud management framework, ultimately reducing costs within the fintech ecosystem.

Vitara Biomedical

Series B in 2022
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Isovalent

Series B in 2022
Isovalent develops open-source software and enterprise solutions for cloud-native networking, security, and observability. Its flagship product, Cilium, enables enterprises to connect, monitor, and secure workloads in modern environments. Isovalent serves leading global organizations and has offices in Cupertino, CA and Zurich, Switzerland.

Kindbody

Venture Round in 2022
Kindbody is a comprehensive fertility clinic network and family-building benefits provider that offers a wide range of services aimed at improving access to healthcare for women. The company provides both virtual and in-person care, including fertility assessments, education, preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. By partnering with employers, Kindbody delivers financial, medical, and emotional support to employees pursuing parenthood. The company serves more than 100 employers, covering over 2.4 million lives, while also providing direct fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. With a focus on affordability and accessibility, Kindbody employs modern technology to deliver holistic health and fertility services.

Lori Systems

Series B in 2022
Founded in 2016, Lori Systems operates a logistics platform that connects transporters with cargo owners. Based in Nairobi, Kenya, with offices in Mombasa, Kampala, and Lagos, the company uses technology to improve transparency, flexibility, reliability, and cost savings (up to 18%) in Africa's $180 billion annual haulage market.

Merlin Labs

Series B in 2022
Founded in 2018, Merlin Labs is based in Boston, Massachusetts. It specializes in developing autonomous flight technology for fixed-wing aircraft, using artificial intelligence and machine learning to enable goods transportation without human pilots.

Progcap

Series C in 2022
Progcap is a fintech lender in India that provides working capital to micro and small businesses, focusing on underbanked semi-urban and rural retailers, underwriting credit with non-traditional ecosystem data and risk models to enable collateral-free financing and supply chain-based funding solutions; founded in 2017 and headquartered in New Delhi, the company leverages technology to deliver affordable and timely credit to its customers.

Medallion

Series C in 2022
Medallion is a San Francisco-based company founded in 2020 by Derek Lo, specializing in a network management platform tailored for the healthcare industry. The company offers an all-in-one solution for licensing, credentialing, and payer enrollment, aimed at simplifying the often cumbersome processes associated with healthcare paperwork. Its platform provides features such as primary source verification, continuing medical education tracking, and document management, enabling healthcare providers and telemedicine companies to minimize time spent on administrative tasks and focus more on patient care.

Courier

Series B in 2022
Courier is a developer of notification management software that enables businesses to efficiently route user notifications across multiple channels, such as email, SMS, and messaging platforms. Its API allows developers to optimize notification delivery by considering various factors, including user engagement history and real-time online status. This flexibility permits the creation of reusable messages that can be tailored for specific channels, ensuring relevant and timely communication. With a strong focus on customer success, Courier has established long-lasting relationships with its clients by continuously adapting to technological advancements and industry changes. The company is committed to maintaining stability in its management while pushing the boundaries of innovation to meet the evolving needs of its customers.

Sesame

Series B in 2022
Sesame, Inc., operating as SesameCare, is a healthcare technology company founded in 2018 and based in New York, New York. The company has developed an innovative platform that enables users to book medical appointments and access healthcare services conveniently and affordably. By leveraging an AI-enabled marketplace, SesameCare eliminates the need for health insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. This approach allows the company to offer Americans high-quality medical care at significantly reduced costs. Additionally, Sesame is recognized as the official telehealth partner of Costco, further enhancing its reach and service offerings.

Wonder

Series B in 2022
Wonder is a technology company that develops an all-in-one gaming platform for Android mobile devices. The platform enables users to play, stream, and share games across devices seamlessly.

Nava

Series B in 2022
Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.

FarmWise

Series B in 2022
FarmWise, established in 2016 and headquartered in San Francisco, specializes in developing and manufacturing robotic machinery for agriculture. The company's primary product is a mechanical weeder, designed to track and remove weeds in vegetable crops, enhancing farm efficiency and reducing herbicide usage. FarmWise also offers comprehensive training and support to ensure optimal use of its technology.

Gametime

Venture Round in 2022
Gametime is a mobile ticketing platform that enables last-minute purchases of tickets to sports, music, and theater events in the United States and Canada. It helps users quickly find nearby options by presenting a curated set of seat choices with price and location comparisons, panoramic photos, and true-to-life venue maps. Tickets are delivered directly to mobile devices for instant access, with venues spanning baseball, football, basketball, hockey, and soccer.

Mirvie

Series B in 2022
Mirvie is a biotechnology company specializing in precise, non-invasive diagnostic tests for maternal-fetal health. Founded in 2018, the company aims to enhance pregnancy safety by providing actionable insights to families and enabling early intervention for potential complications.

Invetx

Series B in 2022
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.

Aspen Neuroscience

Series B in 2022
Aspen Neuroscience develops autologous neuron replacement therapies based on induced pluripotent stem cells to treat neurological conditions, starting with Parkinson's disease. The company uses patient-specific restorative cell therapies by combining pluripotent stem cell biology with genomic approaches and artificial intelligence to address both sporadic and familial forms of Parkinson's disease, focusing on autologous neuron replacement to modify disease progression. Based in San Diego, California, the company is a development-stage biotechnology company pursuing expansion of its iPSC-based platform to other brain disorders.

OMass Therapeutics

Series B in 2022
OMass Therapeutics is a biotechnology company based in Oxford, United Kingdom, that leverages structural mass spectrometry to discover protein-based novel medicines. The company develops a platform that provides access to native mass spectrometry and enables the study of complex protein assemblies and their interactions with biomolecules, allowing biotechnology and pharmaceutical clients to tackle challenging drug targets and biotherapeutics. Through a collaborative framework, OMass Therapeutics supports drug discovery efforts by applying its mass spectrometry technology to identify and characterize potential therapeutic candidates without requiring clients to establish in-house instrumentation and expertise.

Obsidian Security

Series C in 2022
Obsidian Security, Inc. is a cybersecurity company based in Newport Beach, California, established in 2017. It specializes in developing cloud infrastructure and data center security solutions designed to protect hybrid-cloud environments. The company offers advanced threat detection and response capabilities, focusing on business-critical software as a service (SaaS) applications. Through its platform, Obsidian Security provides tools for threat detection, breach remediation, and security hardening, enabling organizations to enhance their cybersecurity posture. By leveraging artificial intelligence, Obsidian Security aims to create a comprehensive understanding of interconnected applications, making them safer and more secure against evolving cyber threats.

Brightline

Series C in 2022
Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.

Celsius Therapeutics

Series B in 2022
Celsius Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for patients suffering from cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a multidisciplinary approach, integrating the expertise of scientists, computational biologists, and clinicians. Celsius Therapeutics utilizes advanced techniques such as single-cell genomic analysis and machine learning to identify and develop innovative therapeutic solutions. By leveraging these cutting-edge technologies, the company aims to create life-changing medicines that address unmet medical needs.

Digits

Series C in 2022
Digits is a fintech company that develops AI-powered accounting platforms. Founded in 2018 by Wayne Chang and Jeff Seibert, the company automates bookkeeping, provides real-time financial insights, and streamlines tax management for startups and small businesses.

LifeMine Therapeutics

Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

Spotlight Therapeutics

Series B in 2022
Founded in 2017, Spotlight Therapeutics develops innovative therapeutics based on its targeted active gene editing platform. The company focuses on creating biologics tailored to specific cell populations, with initial programs in immuno-oncology, ophthalmology, and hematology.

Nothing

Series B in 2022
Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. It aims to remove barriers between people and technology by focusing on product integration and user experience. The company offers mobile devices and personalized noise-cancellation earbuds featuring wireless charging, water resistance, and dual connectivity. Through its innovative approach, Nothing seeks to create a seamless digital ecosystem that combines hardware and software, providing customers with reliable and durable technology at affordable prices.

Redpanda Data

Series B in 2022
Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

RightHand Robotics

Series C in 2022
RightHand Robotics, Inc. is a manufacturer of robotic order-picking systems that streamline supply chain logistics for various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company specializes in robotic solutions that automatically grasp a wide variety of items from bins and cases. Its flagship products include the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor designed to enhance the robots' ability to handle items gently and correct errors. RightHand Robotics focuses on providing end-to-end solutions that simplify integration and adaptation to diverse customer workflows, ultimately reducing the costs associated with order fulfillment across sectors such as electronics, apparel, grocery, and pharmaceuticals.

Genesis Global

Series C in 2022
Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Homebound

Series C in 2022
Homebound is a tech-enabled custom homebuilder that manages the entire construction process for homeowners, from insurance negotiations and architecture to permitting, construction and move-in. Born out of the 2017 Northern California wildfires and based in Santa Rosa, California, the company focuses on rebuilding homes after disasters and uses technology and a network of vetted building professionals to simplify the process and support homeowners at every step.

Ventus Therapeutics

Series C in 2022
Ventus Therapeutics is a biopharmaceutical company focused on discovering and developing innovative small molecule medicines that target the innate immune system. The company employs a structural immunology platform that provides deep insights into molecular structures and mechanisms, enabling precise targeting of the innate immune system. Ventus combines advanced protein engineering capabilities with cutting-edge rational and structure-based drug design tools to create therapeutics aimed at treating autoimmune diseases, inflammatory conditions, and cancer. The company is actively building a diverse pipeline of drug programs that address significant targets within the innate immune system, with the goal of advancing treatments for both acute and chronic inflammatory and immune-related diseases.

Pecan

Series C in 2022
Pecan offers a low-code predictive analytics and data science platform that enables business intelligence, operations, and revenue teams to forecast outcomes without requiring data scientists. The platform simplifies data preparation, automates feature engineering, and provides prebuilt templates and models, allowing SQL-trained analysts to build accurate predictions in days. By turning data into foresight, Pecan helps improve metrics such as customer lifetime value, retention, conversion, and demand forecasting across industries including fintech, insurance, retail, consumer packaged goods, mobile apps, and consumer services. The solution emphasizes easy data connection, automated model training with proprietary algorithms, and actionable recommendations on where to take action, reducing reliance on specialized data science staff and accelerating decision making.

Censys

Series B in 2022
Founded in 2017, Censys offers an internet intelligence platform that provides real-time visibility into global networks and devices. Its solution enables businesses to discover unknown assets, monitor remote workforce, identify threat actors, and manage attack surfaces proactively.

InstaDeep

Series B in 2022
Founded in London in 2015, InstaDeep develops AI-based decision-making systems for enterprises. Its platform offers advanced pattern recognition, GPU-accelerated insights, self-learning systems, machine learning, and predictive analytics to optimize decisions across manufacturing, logistics, mobility, and energy sectors.

Leyden Labs

Series B in 2022
Leyden Labs develops a Mucosal Protection Platform to protect against respiratory viruses, including influenza and coronaviruses. The company offers a portfolio of broad protective nasal sprays designed to reduce the risk of infection and limit transmission, aiming to improve public health through innovative protection methods. Its team combines biotechnology veterans with new talent to advance solutions that address common viral threats at the mucosal surface.

Sibros

Series B in 2022
Sibros is a technology company that specializes in software-defined vehicle management through its Deep Connected Platform™. This platform integrates real-time data collection, software configuration management, remote updates, and diagnostic commands, all while adhering to stringent automotive safety, security, and data privacy standards. Sibros's solutions are versatile and can be implemented across various vehicle architectures, including legacy gas and diesel engines, next-generation battery electric vehicles, fuel cells, motorcycles, buses, commercial trucks, and heavy machinery. By leveraging advanced technology developed in Silicon Valley, Sibros empowers original equipment manufacturers (OEMs) to enhance customer experiences, reduce costs, and explore new revenue opportunities throughout the entire mobility product life cycle. The company's software manages a vehicle's complete software inventory and configurations, facilitating the delivery of connected vehicle services and personalized mobility solutions at scale.

Mill Industries

Series B in 2022
Mill Industries develops and rents smart kitchen bins that chop, dry, shrink, and deodorize food waste overnight, turning it into a coffee‑ground‑like material. The system is digitally connected, allowing users to monitor usage and receive free shipping of the dried residue to a partner facility that converts it into animal feed or compost. By reducing household waste and enabling efficient recycling, the company addresses climate‑related food waste challenges.

Found

Series B in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.